Investing in France for Potent Drug Manufacturing | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Investing in France for Potent Drug Manufacturing

Frederic Desdouits (Managing Director, SEQENS CDMO)

Location: Exhibitor Showcase Theater

Date: Wednesday, May 1

Time: 3:00pm - 3:25pm

Vault Recording: TBD

Shifting needs in the pharmaceutical market are driving a demand for the manufacture of highly potent active pharmaceutical ingredients at a variety of scales. By building a new potent unit that expands our potent compound production capabilities from small to commercial scale, Seqens is expanding the scope of our contract manufacturing services.